Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Accelera Pharma is a Canadian pharmaceutical commercialization, importation, and distribution company operating as a full-service sponsor, importer of record, and vendor of record for prescription and consumer health products. The company helps manufacturers commercialize medicines in Canada and Australia while retaining control over pricing, brand strategy, and customer engagement. Its services span regulatory support, GMP compliance, market access, logistics, warehousing, distribution, and commercial/medical support. Accelera Pharma appears to generate revenue primarily from marketed and distributed products rather than from an internal drug discovery pipeline. Current promoted products include PEGASYS, VIOKACE, HALYCIL, and COMBOGESIC IV, alongside a dermatology-oriented consumer health business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Accelera Pharma.